Enabling the public's early access to good medicines

An internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in drug substance development and manufacturing.

Porton PharmaTech is currently undergoing development, with new constructions and facility enhancements underway.

New facilities include space designated for research and development laboratories and a KILOLAB startup from Q2’24 onwards.

One of the key highlights is the on-going green field investment in a PILOT PLANT designed to host capacity of different unit operations trains, including finalization, QC laboratories and Process Safety Laboratory. The operations are scheduled to start from Q2’25 with qualification of GMP activities by Q1’26.